Bio-Techne (TECH) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts TECH Hot Sheet
Join SI Premium – FREE
Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $2.05, $0.03 worse than the analyst estimate of $2.08. Revenue for the quarter came in at $288.2 million versus the consensus estimate of $287.12 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
